RACGP updates osteoarthritis management guideline to reduce unnecessary imaging, surgery

The Royal Australian College of General Practitioners (RACGP) has announced an update to its guideline for knee and hip osteoarthritis management, saying the policy shift should reduce unnecessary imaging, surgery and medication throughout Australia.

The update aims to get physicians to be more proactive in their management of osteoarthritis, David Hunter, co-chair of the working group responsible for the change, said in an article from RACGP’s newsGP service. It also recommends physicians consider different “preventive and lifestyle treatments” before going straight to imaging or surgery.

“Osteoarthritis is incredibly common and we also know that it’s very poorly managed in many instances,” Hunter said. “We’re really trying to improve appropriateness of care by focusing on the existing evidence to support different interventions for this disease.”

This marks the first time the guideline, “Guideline for the management of knee and hip osteoarthritis,” has been updated in eight years. Australia’s National Health and Medical Research Council approved the changes.

“The change in direction of management of this illness will provide the opportunity for people to live healthy and active lifestyles for years longer than before,” Harry Nespolon, RACGP pident-elect, said in the same article.

More information on the guideline is available here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.